Globally, alcohol use is a leading risk factor for disease burden.
The healthcare community, having eradicated a number of deadly diseases, should approach these alcohol-driven fatalities as a disease and launch a comprehensive, coordinated, and sustained effort to eliminate roadway deaths.
How Medication-Assisted Treatment Affects Outcomes of Alcohol-Dependent Adults With Serious Mental IllnessAugust 02, 2018
Medicine-assisted treatment demonstrated strong benefits following the treatment period, including significantly lower odds for mental health hospitalization and fewer emergency department/crisis visits.
Participants were drawn from the Health and Retirement Study, which provided multiple observations, genetic information, and previous alcohol use.
There have been substantial increases in complete abstinence from substance use reported by high school students over the past 40 years.
Technology-Enhanced Intervention in the ED Appears Promising for Reducing Underage Drinking, ConsequencesJune 28, 2018
This intervention provides flexibility in the clinical setting, allowing for therapist delivery when staff is available and computer delivery when staff resources are not available.
Binge drinking in adolescence may prevent girls from reaching their peak bone mass.
Researchers emphasized the necessity of developing targeted interventions to address such health disparities among American Indian communities.
While many treatments for substance use disorder are not evidence based, several evidence-based approaches have shown effectiveness in court-mandated treatment settings.
Data support lowering limits for alcohol consumption compared with the limits in current guidelines.
Researchers proposed that future projects investigate the geographical and temporal trends in substance use and its disease burden.
A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.
Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence between 1980 and 2014. Mortality rates for drug use disorders increased both nationally and in each county over the same period.
Because even moderate reductions in adolescent drinking and alcohol use disorders have the potential to reduce short- and long-term public health harms, these findings support broad implementation of the program.
Researchers calculated age-standardized mortality rates on a county level in the United States between 1980 and 2014, specifically examining rates for self-harm, interpersonal violence, alcohol use, and drug use.
There has been much variability in the capacity for pharmacological treatments to help curb alcoholism, and the research community has remained interested in determining specific factors that may predict the efficacy of treatments such as naltrexone.
A multisite, cross-sectional study found a large mismatch between previously diagnosed fetal alcohol spectrum disorders and the actual prevalence of cases identified.
Not many high-risk individuals who are motivated to reduce alcohol comsumption are successful after 6 months.
Parents should be advised that this practice is associated with risk, both directly and indirectly through increased access to alcohol from other sources.
Varenicline may have a role in the treatment of alcohol use disorder in men who smoke cigarettes.
These results support the use of reductions in WHO drinking risk levels as an efficacy outcome in clinical trials.
Alcohol use and high-risk drinking were increased from 2001-2002 to 2012-2013.
According to a study presented at the Research Society on Alcoholism, heavy drinking is associated with biological aging at a cellular level.
Women over the age of 60 demonstrate an increased an upward trend in the prevalence of current drinking.
Delays in treatment for psychosis can be associated with poorer outcomes.
Females are also closing the gender gap with regard to health problems associated with alcohol consumption.
Acute exposure to ethanol led to antidepressant and anxiolytic behaviors in rodents for up to 24 hours.
CDC rank alcohol-attributable mortality as the third leading cause of preventable death in the United States.
One topic of criticism is the relative dearth of scientific evidence regarding the efficacy of 12-step programs.
Prdm2 contributes to key behaviors and long-term neuroadaptations associated with alcohol dependence
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Link Identified Between Cured Meat and Mania in Bipolar Disorder
- Suicide Attempts Associated With Sleep and Circadian Rhythm Disturbances in Bipolar Disorder
- First-Episode Delusional Disorder vs Schizophrenia: Assessment of Outcomes
- Early Risk Factors for Bipolar Disorder Found in Offspring of BD Parents
- Probiotics, Depression, and the Role of Inflammation
- The Opioid System: The Foundation for Social Risk and Reward
- Correctional Psychiatry: Challenges and Rewards
- Those Left Behind: Working With Suicide-Bereaved Families
- The Impact of Deafness on Hallucinations and Delusions
- Is Mandatory Reporting of Child Maltreatment in the Best Interests of the Child?
- Nutrition Tips for Physicians: Staying Healthy During Busy Days
- Mental Health Problems in Adolescents With HIV: Overview & Expert Interview
- Should Physicians Play a Role in Minimizing the Societal Cost of Medical Care?
- Digital Cognitive Behavioral Therapy Effective for Individuals With Insomnia
- How Do Medical Scribes Reduce EHR Documentation Burden for Physicians?